Blackrock Equity Method Investments decreased by 99.0% to $24.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 99.1%, from $2.78B to $24.00M. Over 2 years (FY 2023 to FY 2025), Equity Method Investments shows a downward trend with a -90.7% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|
| Value | $2.76B | $2.80B | $2.78B | $2.83B | $2.47B | $2.47B | $24.00M |
| QoQ Change | — | +1.7% | -0.7% | +1.8% | -12.8% | -0.2% | -99.0% |
| YoY Change | — | — | +1.0% | — | — | -12.0% | -99.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.